ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 34 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,035,000 | -1.0% | 375,000 | -12.5% | 0.00% | 0.0% |
Q2 2022 | $1,045,000 | -52.3% | 428,360 | -22.9% | 0.00% | -55.6% |
Q1 2022 | $2,190,000 | +15.1% | 555,895 | +28.8% | 0.01% | +12.5% |
Q4 2021 | $1,903,000 | +46.9% | 431,435 | +105.9% | 0.01% | +33.3% |
Q3 2021 | $1,295,000 | -13.3% | 209,490 | +11.0% | 0.01% | -14.3% |
Q2 2021 | $1,493,000 | +11.6% | 188,690 | +51.0% | 0.01% | +16.7% |
Q1 2021 | $1,338,000 | – | 125,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 245,000 | $676,000 | 0.76% |
BVF INC/IL | 2,326,710 | $6,422,000 | 0.26% |
Cormorant Asset Management, LP | 1,223,500 | $3,377,000 | 0.24% |
Ikarian Capital, LLC | 221,830 | $612,000 | 0.12% |
JMAC ENTERPRISES LLC | 54,538 | $151,000 | 0.04% |
Woodline Partners LP | 516,675 | $1,426,000 | 0.02% |
Eversept Partners, LP | 67,743 | $186,971 | 0.02% |
INGALLS & SNYDER LLC | 51,149 | $141,000 | 0.01% |
Point72 Asset Management, L.P. | 375,000 | $1,035,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 22,050 | $61,000 | 0.00% |